Journal
BIOCHEMICAL SOCIETY TRANSACTIONS
Volume 47, Issue -, Pages 1327-1339Publisher
PORTLAND PRESS LTD
DOI: 10.1042/BST20190225
Keywords
-
Categories
Funding
- Deutsche Forschungsgemeinschaft
- Gertraud und Heinz-Rose Stiftung
- European Research Area Network on Cardiovascular Diseases (ERA-CVD)
Ask authors/readers for more resources
3',5'-Cyclic guanosine monophosphate (cGMP) is one of the major second messengers critically involved in the regulation of cardiac electrophysiology, hypertrophy, and contractility. Recent molecular and cellular studies have significantly advanced our understanding of the cGMP signalling cascade, its local microdomain-specific regulation and its role in protecting the heart from pathological stress. Here, we summarise recent findings on cardiac cGMP microdomain regulation and discuss their potential clinical significance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available